| Biological Sciences | Lifetime | 602 | FR 12 | 99.93 |
| Molecular Biology | Lifetime | 143 | FR 3 | 99.94 |
| Epidemiology | Lifetime | 654 | FR 26 | 99.18 |
| Surgery | Lifetime | 942 | FR 16 | 99.11 |
| Medical Physiology | Lifetime | 581 | FR 9 | 99.01 |
| Oncology | Lifetime | 530 | FR 24 | 99.03 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 482 | FR 8 | 98.55 |
| Cancer Research | Lifetime | 459 | FR 9 | 97.14 |
| Endocrine and Autonomic Systems | Lifetime | 284 | FR 10 | 95.21 |
| Biochemistry | Lifetime | 514 | FR 8 | 92.37 |
| Epidemiology | 2021-2025 | 607 | FR 24 | 94.40 |
| Endocrine and Autonomic Systems | 2021-2025 | 117 | FR 6 | 82.02 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 3 | FR 1 | 99.96 |
| Adipose Tissue and Metabolism | Lifetime | 16 | FR 1 | 99.92 |
| Drug Transport and Resistance Mechanisms | Lifetime | 15 | FR 1 | 99.83 |
| Metabolism, Diabetes, and Cancer | Lifetime | 14 | FR 1 | 99.87 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 19 | FR 1 | 99.85 |
| Cancer, Lipids, and Metabolism | Lifetime | 24 | FR 1 | 99.84 |
| Cholesterol and Lipid Metabolism | Lifetime | 11 | FR 1 | 99.75 |
| Liver Disease Diagnosis and Treatment | Lifetime | 183 | FR 19 | 99.71 |
| Retinoids in leukemia and cellular processes | Lifetime | 43 | FR 6 | 99.26 |
| Lipid metabolism and disorders | Lifetime | 34 | FR 1 | 99.31 |
| Diabetes Treatment and Management | Lifetime | 149 | FR 2 | 99.33 |
| Immune cells in cancer | Lifetime | 180 | FR 7 | 98.87 |
| Dietary Effects on Health | Lifetime | 51 | FR 1 | 98.44 |
| Inflammatory mediators and NSAID effects | Lifetime | 221 | FR 6 | 98.41 |
| Lipid metabolism and biosynthesis | Lifetime | 119 | FR 3 | 98.37 |
| Diet, Metabolism, and Disease | Lifetime | 307 | FR 8 | 98.37 |
| Estrogen and related hormone effects | Lifetime | 474 | FR 18 | 98.22 |
| Lipoproteins and Cardiovascular Health | Lifetime | 401 | FR 8 | 98.31 |
| Nuclear Receptors and Signaling | Lifetime | 137 | FR 8 | 97.74 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 357 | FR 7 | 97.70 |
| Pancreatic function and diabetes | Lifetime | 874 | FR 32 | 97.78 |
| Circadian rhythm and melatonin | Lifetime | 383 | FR 17 | 97.51 |
| Hormonal Regulation and Hypertension | Lifetime | 743 | FR 33 | 97.06 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 883 | FR 28 | 95.00 |
| NF-κB Signaling Pathways | Lifetime | 655 | FR 22 | 94.68 |
| Macrophage Migration Inhibitory Factor | Lifetime | 772 | FR 14 | 82.77 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 2 | FR 1 | 98.46 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 383 | FR 15 | 98.12 |
| Adipose Tissue and Metabolism | 2021-2025 | 307 | FR 6 | 93.52 |
| Dietary Effects on Health | 2021-2025 | 221 | FR 5 | 85.98 |
| Circadian rhythm and melatonin | 2021-2025 | 518 | FR 17 | 87.17 |
| Diet, Metabolism, and Disease | 2021-2025 | 771 | FR 11 | 83.69 |
| Drug Transport and Resistance Mechanisms | 2021-2025 | 568 | FR 12 | 80.43 |